Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope

NCT01357967 is registered in ClinicalTrials.gov with Inje University as lead sponsor.

NCT NCT01357967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01357967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope
Lead sponsor
Inje University
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2011
Completion date
April 30, 2013
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder